COVAXIN Vaccine Current Affairs, GK & News

Australia recognises India’s Covaxin

Australian Government has recognised Covaxin covid-19 vaccine of India on November 1, 2021. Highlights In India, Covaxin and Covishield are the two widely used vaccines. Australia had recognised Covishield, already. The Therapeutic Goods Administration (TGA) of Australia has recognised Covaxin as well as BBIBP-CorV vaccines for establishing a traveller’s vaccination status. Covaxin vaccine has been ..

Month: 

Category: 

Topics: 

WHO seeks clarifications from Bharat Biotech on Covaxin

According to World Health Organisation (WHO), additional clarifications from manufacturer are required to conduct final Emergency Use Listing (EUL) risk-benefit assessment for using Bharat Biotech’s Covaxin globally. Key Points Technical advisory group are now scheduled to meet on November 3 for final assessment. Bharat Biotech has been submitting data on rolling basis to the WHO. ..

Month: 

Category: 

Topics: 

Covaxin approved for emergency use in 2–18-year-olds

The Subject Expert Committee on Covid-19 has approved the “emergency use” of Bharat Biotech’s Covaxin vaccine for children aged between 2-18 years old. Key Points Phase-2 and Phase-3 trials of the Covaxin vaccine by Hyderabad-based Bharat Biotech on children below the age of 18 years in the months of September. Trial data was submitted to ..

Month: 

Category: 

Topics: 

WHO Chief Scientist: Covid vaccination is not absolute protection

Chief scientist of World Health Organisation (WHO), Dr. Soumya Swaminathan, noted that though Covid-19 vaccines may not provide absolute protection against emerging variants of the coronavirus. However, it can reduce risks of death and complications. Highlights Dr Swaminathan further emphasised that, people need to be on guard in upcoming months. She noted that, in a ..

Month: 

Category: 

Topics: 

COVAXIN trial starts on children

Trial of COVAXIN, a COVID-19 vaccine by Bharat Biotech, on children below 18 years was started at All India Institute of Medical Sciences (AIIMS), Patna. Background Trail was started following a nod given on May 11 by Drugs Controller General of India (DCGI) to conduct clinical trials of Covaxin. COVAXIN was approved by DCGI, for ..

Month: 

Category: 

Topics: